Scott Walter Baumgartner is a notable inventor based in Thousand Oaks, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibody formulations for disease treatment. With a total of four patents to his name, Baumgartner's work has the potential to impact therapeutic practices significantly.

Latest Patents

Baumgartner's latest patents include a method of treating diseases using an IL-17 receptor antibody formulation. This patent focuses on AM-14 pharmaceutical formulations and therapeutic dosing regimens aimed at treating various diseases. The innovative approach outlined in his patents showcases his commitment to advancing medical science and improving patient outcomes.

Career Highlights

Throughout his career, Scott Walter Baumgartner has worked with prominent companies in the pharmaceutical industry, including Kirin-Amgen, Inc. and Amgen K.A., Inc. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research and development efforts.

Collaborations

Baumgartner has collaborated with esteemed colleagues such as Dingjiang Liu and Holly Zhuohong Huang. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the pursuit of medical advancements.

Conclusion

Scott Walter Baumgartner's contributions to pharmaceutical formulations and his innovative patents highlight his role as a key figure in the field. His work continues to pave the way for new therapeutic approaches, demonstrating the importance of innovation in medicine.

This text is generated by artificial intelligence and may not be accurate.